- Home
- VLGEA vs SIBN Comparison
VLGEA vs SIBN Comparison
Compare VLGEA & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VLGEA | SIBN |
|---|---|---|
| Founded | 1937 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 592.3M | 576.4M |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VLGEA | SIBN |
|---|---|---|
| Price | $41.00 | $12.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $24.13 |
| AVG Volume (30 Days) | 36.5K | ★ 534.4K |
| Earning Date | 03-03-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.41% | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,612,015,000.00 | $67,301,000.00 |
| Revenue This Year | N/A | $16.89 |
| Revenue Next Year | N/A | $14.95 |
| P/E Ratio | $10.31 | ★ N/A |
| Revenue Growth | 0.46 | ★ 21.53 |
| 52 Week Low | $30.08 | $12.50 |
| 52 Week High | $43.35 | $21.89 |
Technical Indicators
Market Signals| Indicator | VLGEA | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 31.14 |
| Support Level | $36.20 | N/A |
| Resistance Level | N/A | $17.05 |
| Average True Range (ATR) | 1.46 | 0.65 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 49.59 | 7.42 |
Price Performance
Historical ComparisonAbout VLGEA Village Super Market Inc.
Village Super Market Inc operates a chain of ShopRite supermarkets, a few of which are in northern New Jersey, southern New Jersey, Maryland, and in northeastern Pennsylvania. The company is a member of Wakefern Food Corporation (Wakefern), a retailer-owned food cooperative and owner of the ShopRite name. It consists of one operating segment, the retail sale of food and nonfood products.
About SIBN SI-BONE Inc.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.